HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandeep Dutta Selected Research

paritaprevir

10/2017Clinical Pharmacokinetics of Dasabuvir.
10/2017Clinical Pharmacokinetics of Paritaprevir.
7/2017Exposure-Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies.
1/2017Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.
1/2017Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment.
7/2016Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.
4/2016Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.
2/2016Drug-Drug Interactions between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir with or without Dasabuvir.
1/2016Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies.
1/2016Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandeep Dutta Research Topics

Disease

14Infections
10/2017 - 07/2015
13Heart Failure
01/2022 - 01/2021
11Epilepsy (Aura)
12/2009 - 01/2003
10Chronic Hepatitis C
02/2018 - 07/2015
6Body Weight (Weight, Body)
01/2021 - 02/2015
4Virus Diseases (Viral Diseases)
02/2018 - 11/2015
4Parkinson Disease (Parkinson's Disease)
01/2017 - 04/2013
3Neoplasms (Cancer)
09/2022 - 01/2020
3Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2020
3Pain (Aches)
02/2015 - 06/2012
2Fibrosis (Cirrhosis)
07/2017 - 01/2017
2Headache (Headaches)
12/2016 - 06/2012
2Hepatitis C
10/2016 - 04/2016
2Neuralgia (Stump Neuralgia)
03/2015 - 06/2012
2Alzheimer Disease (Alzheimer's Disease)
01/2015 - 04/2011
2Schizophrenia (Dementia Praecox)
06/2014 - 04/2011
2Migraine Disorders (Migraine)
03/2007 - 11/2004
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Osteoarthritis
12/2016
1Erythema
12/2016
1Diarrhea
12/2016
1Knee Osteoarthritis
12/2016
1HIV Infections (HIV Infection)
04/2016
1Coinfection
04/2016
1Breast Neoplasms (Breast Cancer)
02/2016
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Dyskinesias (Dyskinesia)
09/2015
1Gout
03/2015
1Postoperative Pain
02/2015
1Multiple Sclerosis
10/2014
1Fever (Fevers)
06/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
06/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2013
1Coronary Stenosis (Coronary Artery Stenosis)
09/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2012
1Vomiting
06/2012
1Nausea
06/2012
1Dizziness (Lightheadedness)
06/2012

Drug/Important Bio-Agent (IBA)

17Antiviral Agents (Antivirals)IBA
02/2018 - 07/2015
14paritaprevirIBA
10/2017 - 07/2015
13omecamtiv mecarbilIBA
01/2022 - 01/2021
12Cardiac MyosinsIBA
01/2022 - 01/2021
12ombitasvirIBA
10/2017 - 07/2015
11Ritonavir (Norvir)FDA Link
10/2017 - 07/2015
11Valproic Acid (Depakote)FDA LinkGeneric
12/2009 - 01/2003
9dasabuvirIBA
10/2017 - 07/2015
4TabletsIBA
01/2022 - 11/2004
4Carbidopa (Lodosyn)FDA LinkGeneric
01/2017 - 04/2013
4Levodopa (L Dopa)FDA LinkGeneric
01/2017 - 04/2013
4EnzymesIBA
03/2006 - 01/2003
3Monoclonal AntibodiesIBA
10/2021 - 10/2014
3Panitumumab (Vectibix)FDA Link
10/2021 - 01/2020
3Proteins (Proteins, Gene)FDA Link
10/2017 - 02/2016
3Ribavirin (Virazole)FDA LinkGeneric
07/2017 - 01/2016
3CreatinineIBA
01/2017 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2021
2glecaprevir and pibrentasvirIBA
02/2018 - 12/2017
2Protease Inhibitors (Protease Inhibitor)IBA
10/2017 - 01/2016
2Pharmaceutical PreparationsIBA
04/2016 - 01/2016
2ABT 102IBA
07/2012 - 01/2012
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2012 - 04/2011
2Anticonvulsants (Antiepileptic Drugs)IBA
03/2006 - 01/2003
1Rosuvastatin Calcium (Crestor)FDA Link
11/2021
1NucleosidesIBA
10/2017
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2017
1Opioid Analgesics (Opioids)IBA
01/2017
1CytokinesIBA
12/2016
1InterleukinsIBA
12/2016
1lutikizumabIBA
12/2016
1A 7 (A-7)IBA
12/2016
1Tacrolimus (Prograf)FDA LinkGeneric
10/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2016
1Human immunodeficiency virus 1 p16 proteaseIBA
04/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2016
1glucose 6-phosphate(transporter)IBA
02/2016
1SofosbuvirIBA
02/2016
1Rilpivirine (TMC-278)IBA
01/2016
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2016
14- chloro- 2- fluoro- N- (2- fluorophenyl)- 5- (hexahydropyrrolo(1,2- a)pyrazin- 2(1H)- ylcarbonyl)benzenesulfonamideIBA
03/2015
1Uric Acid (Urate)IBA
03/2015
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
03/2015
1Acetaminophen (Paracetamol)FDA LinkGeneric
02/2015
1Hydrocodone (Dihydrocodeinone)FDA LinkGeneric
02/2015
1Donepezil (Aricept)FDA LinkGeneric
01/2015
1ApolipoproteinsIBA
01/2015
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2015
1Daclizumab (Zenapax)FDA Link
10/2014
1Interleukin-2 Receptors (IL 2 Receptor)IBA
10/2014
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2014
12- (4'- (5- methylhexahydropyrrolo(3,4- b)pyrrol- 1- yl)biphenyl- 4- yl)- 2H- pyridazin- 3- oneIBA
06/2014
1Antipsychotic Agents (Antipsychotics)IBA
06/2014
13-methoxytyrosineIBA
04/2013
1N- (5- (aminocarbonyl)tricyclo(3.3.1.13,7)dec- 2- yl)- alpha,alpha- dimethyl- 4- (5- (trifluoromethyl)- 2- pyridinyl)- 1- piperazineacetamideIBA
04/2013
1Cytidine Triphosphate (CTP)IBA
09/2012
15-(2-azetidinylmethoxy)-2-chloropyridineIBA
06/2012
1Morphine (MS Contin)FDA LinkGeneric
06/2012
1LigandsIBA
06/2012

Therapy/Procedure

7Therapeutics
09/2022 - 12/2009
2Oral Administration
09/2015 - 07/2014
1Liver Transplantation
10/2016